Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics

被引:138
作者
Bird, A. R. [1 ,2 ]
Conlon, M. A. [1 ,2 ]
Christophersen, C. T. [1 ,2 ]
Topping, D. L. [1 ,2 ]
机构
[1] CSIRO Food & Nutr Sci, Food Futures Natl Res Flagship, Adelaide, BC 5000, Australia
[2] CSIRO Food & Nutr Sci, Preventat Hlth Natl Res Flagship, Adelaide, BC 5000, Australia
关键词
microbiota; short chain fatty acids; colon; fibre; human health; CHAIN FATTY-ACIDS; AMYLOSE MAIZE STARCH; COLORECTAL-CANCER; DIETARY FIBER; BIFIDOBACTERIUM-LONGUM; BACTERIAL FERMENTATION; INTESTINAL FLORA; BUTYRATE ENEMAS; COLONOCYTE DNA; MICROBIOTA;
D O I
10.3920/BM2010.0041
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The metabolic end products of the large bowel microbiota contribute significantly to human health. After weaning to solid foods, some of the most important of these are the short chain fatty acids (SCFA) produced by the fermentation of undigested dietary components and endogenous secretions. The main SCFA are acetate, propionate and butyrate which have numerous documented effects promoting large bowel function. Of the major acids, butyrate seems especially important. It is a major metabolic fuel for colonocytes and promotes a normal phenotype in these cells, potentially lowering the risk of diseases such as colo-rectal cancer. Imbalances in the microbiota are thought to predispose to large bowel dysfunction and probiotics are being developed to correct this. However, most commercial products contain bacteria (lactobacilli and bifidobacteria) which are dominant species in milk-fed infants but have limited roles in adults. Prebiosis is defined usually by the specific stimulation of these bacteria. However, the end products of most probiotics do not include butyrate or propionate which raises questions about their effectiveness in promoting bowel health in adults. Resistant starch (RS) is a dietary fibre component and its fermentation generally favours butyrate production. Dietary RS intakes and faecal butyrate levels are high in populations at low risk of diet-related large bowel diseases. Conversely, RS intakes and faecal butyrate levels are very low in high risk groups. This raises the possibility that greater RS consumption could be of health benefit. RS is not regarded widely as a prebiotic but (according to the accepted definition) most forms show the requisite features in stimulating specific bacteria, giving raised total SCFA and butyrate levels and a consequent benefit to the host. Current efforts to improve public health through increasing RS consumption could be facilitated by greater recognition of its prebiotic role.
引用
收藏
页码:423 / 431
页数:9
相关论文
共 88 条
  • [1] Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch
    Abell, Guy C. J.
    Cooke, Caroline M.
    Bennett, Corinna N.
    Conlon, Michael A.
    McOrist, Alexandra L.
    [J]. FEMS MICROBIOLOGY ECOLOGY, 2008, 66 (03) : 505 - 515
  • [2] Ahmed R, 2000, AM J GASTROENTEROL, V95, P1017, DOI 10.1111/j.1572-0241.2000.01848.x
  • [3] FUEL UTILIZATION IN COLONOCYTES OF THE RAT
    ARDAWI, MSM
    NEWSHOLME, EA
    [J]. BIOCHEMICAL JOURNAL, 1985, 231 (03) : 713 - 719
  • [4] Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life
    Arslanoglu, Sertac
    Moro, Guido E.
    Schmitt, Joachim
    Tandoi, Laura
    Rizzardi, Silvia
    Boehm, Gunther
    [J]. JOURNAL OF NUTRITION, 2008, 138 (06) : 1091 - 1095
  • [5] ASP NG, 1992, EUR J CLIN NUTR, V46, pS1
  • [6] Baghurst PA, 1996, FOOD AUST, V48, pS3
  • [7] Butyrylated starch protects colonocyte DNA against dietary protein-induced damage in rats
    Bajka, Balazs H.
    Clarke, Julie M.
    Cobiac, Lynne
    Topping, David L.
    [J]. CARCINOGENESIS, 2008, 29 (11) : 2169 - 2174
  • [9] Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study
    Bingham, SA
    Day, NE
    Luben, R
    Ferrari, P
    Slimani, N
    Norat, T
    Clavel-Chapelon, F
    Kesse, E
    Nieters, A
    Boeing, H
    Tjonneland, A
    Overvad, K
    Martinez, C
    Dorronsoro, M
    Gonzalez, CA
    Key, TJ
    Trichopoulou, A
    Naska, A
    Vineis, P
    Tumino, R
    Krogh, V
    Bueno-de-Mesquita, HB
    Peeters, PHM
    Berglund, G
    Hallmans, G
    Lund, E
    Skeie, G
    Kaaks, R
    Riboli, E
    [J]. LANCET, 2003, 361 (9368) : 1496 - 1501
  • [10] Bird A R, 2000, Curr Issues Intest Microbiol, V1, P25